A Phase 1 Study to Determine the Relative Bioavailability of ACH-0144471 After Administration of a Tablet or Softgel Capsule Versus a Liquid Filled Capsule in Healthy Volunteers
Latest Information Update: 06 Nov 2023
At a glance
- Drugs Danicopan (Primary)
- Indications Glomerulonephritis; Haemolytic uraemic syndrome; Paroxysmal nocturnal haemoglobinuria
- Focus Pharmacokinetics
- Sponsors Achillion Pharmaceuticals; Alexion AstraZeneca Rare Disease
- 06 May 2017 Status changed from recruiting to completed.
- 03 Aug 2016 New trial record